Neurol. praxi. 2009;10(2):80-82

Neuropsychobiology of suicide

prof. MUDr. Peter Kukumberg Ph.D
II. neurologická klinika LF UK FNsP akademika L. Dérera v Bratislave

Suicide is a fatal act of ultra-extreme judgement, determination, and conduct. It appears as a destructive antipole of the instinct

of self-preservation or as a terrifying self-execution of an individual being one‘s own judge, advocate, and executioner. In causal and

empirical terms, it most commonly occurs with a depressive disorder, schizophrenia, decompensated abuse, conditions following spinal

cord trauma, multiple sclerosis, Parkinson‘s disease, Huntington‘s disease, and epilepsy. It does not occur among animals. There is

no systemic prevention. Numerous but inconclusive findings (mostly post mortem) indicate that neurotransmitters (serotonin, dopamine,

GABA, etc.) and/or other substances in the blood, cerebrospinal fluid, tissue, and urine are involved in suicidal behaviour and action.

There is no clear evidence of a genetic deviation. No suicidal markers have been established. Suicide represents an extremely serious

sociological-medical problem with poor prevention and is among the five leading causes of death.

Keywords: suicide, suicide definitions, suicide prevention, sociological-medical phenomenon of suicide, neurotransmitters, depressive disorder, Parkinson‘s disease, Huntington‘s disease, multiple sclerosis, epilepsy.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kukumberg P. Neuropsychobiology of suicide. Neurol. praxi. 2009;10(2):80-82.
Download citation

References

  1. Asberg M, Thoren P, Traskman L., ,Serotonin depresssion" - a biochemical subgroup within the affective disorder? Science 1976; 191: 478-480. Go to original source... Go to PubMed...
  2. Banki MC, Vojnik M, Papp Z. Cerebrospinal fuid magnesium and calcium related to amine metabolities, diagnosis, and suicide attempts. Biol Psychiatry 1985; 20: 163-171. Go to original source... Go to PubMed...
  3. Barraclough BM. The suicide role of epilepsy. Acta Psychiatr Scand 1987; 76: 339-347. Go to original source... Go to PubMed...
  4. Engelberg H. Low serum cholesterol and suicide. Lancet 1992; 339: 727-729. Go to original source... Go to PubMed...
  5. Enna SJ. Brain serotonin receptors and neuropsychiatric disorders. Adv Exp Med Biol 1981; 133: 347-357. Go to original source... Go to PubMed...
  6. Frankl EV. Lékařská péče o duši. Brno: Cesta 1996. 240 s.
  7. Joffe RT, Lippert GP, Gray TA. Mood disorder and multiple sclerosis. Arch Neurol 1987; 44: 376-378. Go to original source... Go to PubMed...
  8. Kutcher S, Chehil S. Suicide Risk Management. Lundbeck Institute, Blackwell 2007. 134 s. Go to original source...
  9. Lindberg G, Rastam L, Gulberg B. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 1990; 301: 309-314. Go to PubMed...
  10. Mitchell JA. Neuropsychiatry and Behavioral Neurology Explained. Saunders 2004. 525 s.
  11. Motlová L, Koukolík F. Citový mozek. Praha: Galén 2006. 359 s.
  12. Moudrost věků. Lexikon latinských výroků, přísloví a rčení. Praha: Svoboda 1994. 679 s.
  13. Roy A, Agren H, Pickar H. Reduced CSF concentration of homovanillacid and homovanillic acid to 5-hydroxyindoleacetic ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppresion. Am J Psychiatry 1986; 143: 1539-1545. Go to original source... Go to PubMed...
  14. Rujesco D, Giegling, Sato R. Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta analysis. Biol Psychiatry 2003; 54: 465-473. Go to original source... Go to PubMed...
  15. Schiffer BR, Rao MS, Fogel SB. Neuropsychiatry. Second Edition. Philadelphia: Lippincott Williams-Wilkins 2003. 1252 s.
  16. Schoenfeld L, Myers RH, Cupples LA. Increased rate of suicide among patients with Huntington´s disease. J Neurol Neurosurg Psychiatry 1984; 47: 1283-1287. Go to original source... Go to PubMed...
  17. Simko F, Paulis L. Minireview Melatonin as a potential antihypertensive treatment. J Pineal Res. 2007; 42: 319-322. Go to original source... Go to PubMed...
  18. Tibetská kniha moudrých. Praha: Odeon 1991. 165 s.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.